
Cabaletta Bio is a biotechnology business based in the US. Cabaletta Bio shares (CABA) are listed on the NASDAQ and all prices are listed in US Dollars. Cabaletta Bio employs 66 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy Cabaletta Bio stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – CABA. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 in stock when you fund a new account within 30 days
eToro
- Easy to use platform with $0 stock trading & no annual fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100
tastytrade
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
Cabaletta Bio stock price (NASDAQ: CABA)
Use our graph to track the performance of CABA stocks over time.Cabaletta Bio shares at a glance
Latest market close | $10.09 |
---|---|
52-week range | $0.59 - $13.44 |
50-day moving average | $9.50 |
200-day moving average | $6.17 |
Wall St. target price | $14.17 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-1.59 |
Buy Cabaletta Bio stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Is it a good time to buy Cabaletta Bio stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Cabaletta Bio price performance over time
Historical closes compared with the close of $10.09 from 2023-05-31
1 week (2023-05-25) | 7.11% |
---|---|
1 month (2023-05-01) | -11.49% |
3 months (2023-03-01) | 20.98% |
6 months (2022-12-01) | 115.60% |
1 year (2022-06-01) | 688.28% |
---|---|
2 years (2021-05-28) | N/A |
3 years (2020-06-01) | 17.19% |
5 years (2018-05-28) | N/A |
Cabaletta Bio financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -33.45% |
Return on equity TTM | -56.34% |
Profit margin | 0% |
Book value | $2.92 |
Market capitalisation | $373.9 million |
TTM: trailing 12 months
Cabaletta Bio share dividends
We're not expecting Cabaletta Bio to pay a dividend over the next 12 months.
Cabaletta Bio share price volatility
Over the last 12 months, Cabaletta Bio's shares have ranged in value from as little as $0.59 up to $13.44. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cabaletta Bio's is 2.5331. This would suggest that Cabaletta Bio's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Cabaletta Bio overview
Cabaletta Bio, Inc. , a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. The company's lead product candidate is DSG3-CAART, which is in Phase I clinical trial for the treatment of mucosal pemphigus vulgaris, an autoimmune blistering skin disease. Its product candidate pipeline also includes MuSK-CAART, a preclinical stage product to treat a subset of patients with myasthenia gravis; CABA-201, a 4-1BB-containing CD19-CAR T investigational therapy, for the treatment of severe autoimmune diseases; PLA2R-CAART, a discovery stage product to treat patients with PLA2R-associated membranous nephropathy; and DSG3/1-CAART, a discovery stage product for the treatment of mucocutaneous pemphigus vulgaris. It has a collaboration with the University of Pennsylvania and the Children's Hospital of Philadelphia. The company was formerly known as Tycho Therapeutics, Inc. and changed its name to Cabaletta Bio, Inc.
Cabaletta Bio in the news
Cabaletta Bio to Present at the Jefferies Healthcare Conference
Cabaletta Bio to Present at the Jefferies Healthcare Conference
Institutional investors in Cabaletta Bio, Inc. (NASDAQ:CABA) lost 18% last week but have reaped the benefits of longer-term growth
Frequently asked questions
What percentage of Cabaletta Bio is owned by insiders or institutions?Currently 10.981% of Cabaletta Bio shares are held by insiders and 76.358% by institutions. How many people work for Cabaletta Bio?
Latest data suggests 66 work at Cabaletta Bio. When does the fiscal year end for Cabaletta Bio?
Cabaletta Bio's fiscal year ends in December. Where is Cabaletta Bio based?
Cabaletta Bio's address is: 2929 Arch Street, Philadelphia, PA, United States, 19104 What is Cabaletta Bio's ISIN number?
Cabaletta Bio's international securities identification number is: US12674W1099 What is Cabaletta Bio's CUSIP number?
Cabaletta Bio's Committee on Uniform Securities Identification Procedures number is: 12674W109
More guides on Finder
-
JP Morgan Personal Advisors review 2023
Access remote advice, planning and portfolio management from this established financial services company.
-
How to buy Energy Transfer Equity stock
Steps to owning and managing ET, with 24-hour and historical pricing before you buy.
-
How to buy Uranium Energy stock
Steps to owning and managing UEC, with 24-hour and historical pricing before you buy.
-
How to buy Gold Royalty stock
Steps to owning and managing GROY, with 24-hour and historical pricing before you buy.
-
Best apps and platforms for ETF investing
The best trading apps come with low fees and are easy to use.
-
What happens if a brokerage firm fails?
Here’s what happens to your securities if your brokerage fails, and how your assets are protected by SIPC and FDIC.
-
Best online brokers & platforms to buy gold stocks in June 2023
Learn about buying physical gold, plus stocks and ETFs, to learn how you can add gold exposure to your portfolio.
-
Silicon Valley Bank collapse: Which ETFs and stocks are impacted?
Several ETFs have exposure to Silicon Valley Bank, but it appears minimal.
-
How to buy Treasury Bills
Treasury Bills are fixed-income assets with maturities of less than one year. Here’s what to know before investing.
-
SVB collapses: What does it mean for your portfolio?
The 16th largest US bank has collapsed, but its impact on your portfolio could be limited depending on what you own.
Ask an Expert